Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Sep 17 2021;13(9)doi:10.3390/nu13093229 Gana W, De Luca A, Debacq C, et al
)
Special populations and considerations Not everyone approaches regenerative peptides from the same starting point
Blood Glucose GLP-1s effectively lower blood glucose levels Research shows that GLP-1RAs significantly improve glycemic control by enhancing insulin secretion and inhibiting glucagon release, leading to better management of blood sugar levels Cardiovascular Health GLP-1s are associated with a lower risk of major cardiovascular events Meta-analyses reveal that GLP-1RAs reduce the risk of cardiovascular death, non-fatal heart attack, and stroke, offering substantial cardiovascular protection for patients Kidney Health Preserving kidney function Studies suggest that GLP-1RAs help in preserving kidney function and reducing the progression of kidney disease in patients with type 2 diabetes On average, people on GLP-1 Medications lose 1.5% of their weight per week* This product is absolutely incredible
Employers need approaches that balance access with sustainability
It requires ongoing care, support and the right tools to stay on track
